EFMC AND ESMEC ARE OFFERING FREE REGISTRATIONS FOR THE '35th European School of Medicinal Chemistry (ESMEC)'
EFMC and the Scientific Committee of ESMEC are offering 13 (3+10) scholarships for the participation to the XXXIV edition of the school, which will be held on June 28 - July 3 in Urbino, Italy. The scholarships, covering the registration fee and the full board accommodation, will be assigned to PhD students enrolled in Doctoral Schools held in one of the member countries of EFMC, excluding Italy. (…)
(...) Applicants are invited to fill in the application form available on www.efmc.info and to send it along with a CV, a motivation letter and the abstract of the research project, preferably by e-mail, stating in the subject box “ESMEC Application” within March 21st, 2015 to Prof. Carlo De Micheli (e-mail: firstname.lastname@example.org).
A Committee formed by Prof. Carlo De Micheli - Director of ESMEC-Urbino, Prof. Koen Augustyns - President of EFMC, and Prof. Marco Mor - member of the School’s Scientific Committee, will carry out the selection on the basis of the candidate scientific CV.
‘Frontiers in Medicinal Chemistry’ ORGANISED BY THE GERMAN MEDICINAL CHEMISTRY DIVISIONS OF GDCH AND DPHG
The international symposium will focus on state-of-the-art technologies and novel approaches in the field of medicinal chemistry and pharmaceutical research with sessions on RNA-therapeutics, CNS-Neurodegeneration, Antiinfectives and Antivirals, Highlights and Technology in MedChem and Innovative novel drug releases (….)
(…) The scientific program will include plenary lectures, short lectures, and poster presentations. Furthermore, oral communications of postdoctoral junior scientists will be considered. It is the goal of the organizers to make this meeting an event of scientific excellence, attractive to both industrial and academic scientists in Medicinal Chemistry and related fields of research.
More information: https://www.gdch.de/veranstaltungen/tagungen/gdch-tagungen-2015/frontiers-in-medicinal-chemistry.html#c1738
THE DUTCH MEDICINAL CHEMISTRY SOCIETY (KNCV) ORGANISES THE 2015 SPRING MEETING ON ‘Medicinal Chemistry of Protein-Protein Interactions: Challenges and Opportunities’
This one-day, EFMC-sponsored event, will be held in Utrecht, March 27, 2015.
More information available at: www.kncv.nl/fc-reg-2015
THE AUSTRIAN CHEMICAL SOCIETY (GÖCh) ANNOUNCES THE '16th Austrian Chemistry Days'
The meeting, jointly organised with the Italian Chemical Society, will be held in Innsbruck, September 21-24, 2015. The meeting will focus on the central role of advances in synthesis is emphasized. This comprises synthetic methodologies from molecular up to solid state chemistry. These tasks afford joint contributions from all fields of chemistry, including medicinal chemistry (…)
(…) In the past the Austrian Chemistry Days have been organised in cooperation with the chemical societies of Slovakia, Slovenia, the Czech Republic, and Hun-gary. Members of these societies are particularly welcome to participate. In 2015 we are glad to share this meeting with the Italian Chemical Society. As in recent years, the language of the conference will be English. More information available at http://www.goech.at
NEWS FROM THE BIOLOGICAL AND MEDICINAL CHEMISTRY SECTOR (BMCS)
The Biological and Medicinal Chemistry Sector (BMCS) has a wide program of activities and events for the year 2015, which are reported here (….)
Malcolm Campbell Memorial Prize 2015: Announcement of Winners
The Biological and Medicinal Chemistry Sector of the RSC is proud to announce the winners of the Malcolm Campbell Memorial Prize for 2015. The prize has been awarded to Miles Congreve, Fiona Marshall and Malcolm Weir for the seminal contributions to GPCR drug discovery made by Heptares Therapeutics Ltd since the company was founded in 2007.
This work has included building the world-renowned StaR© technology platform for X-ray crystallography of GPCRs and the invention of a number of clinical candidates. The winners are particularly commended on their outstanding publication record, and on their willingness to release data into the public domain.
The Malcolm Campbell Memorial prize commemorates Professor Campbell’s outstanding contributions in a broad range of chemistry and their applications to the understanding of bioactivity. The prize is awarded biennially and the 2015 prize will be presented formally to the winning team during the 18th RSC/SCI Medicinal Chemistry Symposium to be held at Churchill College in Cambridge on 13th to 16th September 2015.
The BMCS Committee wishes to express its gratitude for the high-quality entries from both academia and industry for the 2015 award
2015 BMCS Travel Prizes: Announcement of Awardees
The Biological and Medicinal Chemistry Sector (BMCS) is pleased to announce the winners of the 2015 BMCS Travel Prize. From a large number of very high quality applicants the judges selected the following individuals: Marta Brambilla (Oxford University); Chris Brown (Bristol University); Ewen Calder (Glasgow University); Miguel Garzon Sanz (Birmingham University); Gemma Geary (Leicester University); Maria Shchepinova (Glasgow University). Recognising that early-career researchers (ECRs) are the potential Nobel prize-winners of the future, the BMCS introduced the Travel Prize programme in 2014 to help support, encourage and develop the training of next-generation research leaders. The winners receive funding of up to £1500 to support their attendance and travel to high impact international conferences relevant to their projects. The BMCS judging panel was both pleased and overwhelmed by the very high quality and numbers of applications to this, the second running of the Travel Prize Programme; the Chair of the panel Dr. Andrew Williams commented "If anything the quality of the applications in the second year of this initiative was even higher than in the first in 2014, and the increased number gave the judges an even bigger headache. My sincere congratulations and thanks go to all the applicants."
Information about applications for the 2016 BMCS Travel Prizes will be available later in the year, check www.rsc.org/bmcs for further information
RSC Biological and Medicinal Chemistry Sector Lectureship
Dr Mike Waring, who is a Principal Scientist and Associate Science Director in Medicinal Chemistry at AstraZeneca in Alderley Park, was chosen as the winner of the first RSC Biological and Medicinal Chemistry Lectureship Award. The award was initiated to stimulate interest and awareness among the general public of the role of medicinal chemistry in the discovery of life-saving new medicines and to inspire the next generation of young chemists. The list of nominees was extremely strong and Mike was a worthy winner
Following his augural lecture at Burlington House on 1st May 2014, he gave a talk at a half day student symposium at the University of Manchester on 8th October and has spoken at the University of Lancaster. Mike will be giving a series of talks throughout the UK in 2015 entitled ‘Molecular Oncology – Past, Present and Future of Anti-Cancer Drug Design’. The winner of the second RSC Biological and Medicinal Chemistry Lectureship Award is Professor Barry Potter from the University of Bath who will be giving his series of lectures in 2015/2016
8th RSC BMCS Biological and Medicinal Chemistry Postgraduate Symposium
Department of Chemistry, Cambridge University on 12th December 2014
This symposium was the latest in the annual series designed to showcase the very best postgraduate research in the field of biological chemistry and medicinal chemistry. There were eight postgraduate oral presentations of 30 minutes while the lunch-time postgraduate poster session had 18 contributors. The symposium also uses the Flash Poster format to invigorate the poster session, where the poster presenters 'pitch' a 2 minute slide to the audience to attract them to their poster, a format which has always generated lots of discussion. There were also three plenary speakers; Nicole Hamblin of GSK who talked the audience through the discovery of a new medicine for the control of both asthma and COPD in a talk entitled ‘Discovery and Development of Inhaled PI3Kδ Inhibitor GSK2269557’, Charlie Mowbray of DNDi, a not-for-profit organisation which discovers and develops new treatments for patients suffering from Neglected Tropical Diseases (NTDs), who talked about ‘New approaches to drug discovery for Neglected Tropical Diseases’, and Matt Fuchter from Imperial College London who encouraged the audience to consider a career in academic medicinal chemistry in his presentation ‘Histone methyltransferase inhibitors: Fast acting molecules against blood and liver stage malaria parasites’. Registration for the Symposium was free and the meeting was attended by around 150 scientists whose feedback to an online questionnaire has been overwhelmingly positive
NB The 9th symposium in this series will be held on Friday 11th December 2015 in the Chemistry Department at the University of Cambridge
Prizes were awarded for the best oral presentation and the best poster presentation as well the runner-up in each category. The winner of the oral prize, Charlotte Sutherell from Cambridge University, has the opportunity to represent the UK at a satellite symposium on 17th September 2015 to the ‘Frontiers in Medicinal Chemistry’ symposium which will be held on 14-16th September, 2015 in Antwerp. At this event, ‘The Young Medicinal Chemists Symposium’, Charlotte will compete against the winners of the other EFMC student postgraduate symposia
The prizes were awarded as follows:
||Charlotte Sutherell, Cambridge University
||Natalie Theodoulou, University of Strathclyde
||Niall Igoe, University College London
||Ben Whitehurst, University of Strathclyde
The participant’s prize for best poster was won by Ricky Cain from the University of Leeds
Mastering MedChem: 1st RSC-BMCS symposium on mastering medicinal chemistry
26th February 2015, Royal Society of Chemistry, London, UK
Fragments 2015: Fifth RSC-BMCS Fragment-based Drug Discovery meeting
22nd to 24th March 2015, Churchill College, Cambridge, United Kingdom
Late fees apply from 21st February
Proteinase 2015: 9th RSC / SCI symposium on proteinase inhibitor design
13th to 14th April 2015, Novartis, Basel, Switzerland
Closing date for poster submissions is 23rd February
Nucleosides and nucleotides: synthetic and biological chemistry
17th April 2015, Royal Society of Chemistry, London, UK
Closing date for poster submissions is 6th March
26th symposium on medicinal chemistry in eastern England (Hatfield)
23rd April 2015, The Fielder Centre, Hatfield, UK
Closing date for bursary applications is 30th March
18th RSC / SCI Medicinal Chemistry symposium
13th to 16th September 2015, Churchill College, Cambridge, UK
Closing date for poster submissions is 24th July
Website: not yet available
SPANISH SOCIETY OF MEDICINAL CHEMISTRY (SEQT) AND THE ITALIAN DIVISION OF MEDICINAL CHEMISTRY JOINTLY ORGANISES THE 'Spanish Italian Medicinal Chemistry Congress (SIMCC2015)'
The Spanish Society of Medicinal Chemistry (SEQT) and the Italian Division of Medicinal Chemistry (SCI-DCF) jointly organise the Spanish-Italian Medicinal Chemistry Congress (SIMCC) in Barcelona, July 12-15, 2015 (…)
The Spanish Society of Medicinal Chemistry (SEQT) and the Italian Division of Medicinal Chemistry (SCI-DCF) will hold a joint conference in 2015.
The Spanish-Italian Medicinal Chemistry Congress (SIMCC 2015) will take place from 12 to 15 July 2015 at the Barcelona Biomedical Research Park (PRBB).
In the frame of the close relationship between both Societies, this Congress will give the opportunity to delegates to strengthen scientific ties and develop common interests and joint collaborative efforts. Of course, we hope these goals will involve not only Spanish or Italian participants but also scientists from other countries active in different areas of the Medicinal Chemistry field.
The Congress will feature a rich scientific program that offers a broad outlook into the Medicinal Chemistry world. This is particularly important for young people attending the Congress, in order to expand their scope about the future trends of their professional career. Thus, in addition to updates on choice topics and future trends in Medicinal Chemistry, there will be keynote lectures, invited speaker presentations, short oral communications and poster exhibits on drug discovery advances in selected therapeutic areas. The program will also cover recent progress in lead identification and optimization, drug design and profiling technologies, as well as highlight current challenges in the interface between chemistry and biology.
- Simone Braggio. Aptuit, Verona, Italy
- Helmut Buschmann. Pharma-Consulting Aachen, Germany
- Igor Larrosa. University of Manchester, United Kingdom
- Pilar Marco. Institute for Advanced Chemistry of Catalonia-CSIC
- Jean Martínez. University of Montpellier, France
- Roberto Pellicciari. TES Pharma, Perugia, Italy
- María Jesús Vicent. Centro de Investigación Príncipe Felipe, Valencia, Spain
- Vincenza Andrisano. University of Bologna, Italy
- Coral Barbas. University San Pablo-CEU, Madrid, Spain
- Paolo Caliceti. University of Padova, Italy
- Andrea Cavalli. University of Bologna, Italy
- Gerhard Müller. Mercachem, Nijmegen, The Netherlands
- María Jesús Pérez-Pérez. Instituto de Química Médica-CSIC, Madrid, Spain
- Francesco Peri. University of Milano, Italy
- Eugenio Vázquez. University of Santiago de Compostela, Spain
A preliminary program is available. Abstract submission and registration started in January 2015. For further information and regular updates, please visit our website (http://www.simcc2015.org/).
We are all looking forward to welcoming you in Barcelona
NEWS FROM THE HELLENIC SOCIETY OF MEDICINAL CHEMISTRY (HSMC)
The Hellenic Society of Medicinal Chemistry is very active in the organization of meetings and congresses. Here a summary of the forthcoming initiatives and a report of the past ones (…)
Report on the 1st International Congress: From Drug Discovery to Drug Delivery, 13-15 November, 2014, Royal Olympic Hotel, Athens, Greece
The 1st International Congress: From Drug Discovery to Drug Delivery took place at Royal Olympic Hotel in Athens, Greece, on 13-15 November 2014. The Congress was co-organised by the Hellenic Pharmaceutical Society (HPS), the Hellenic Society of Medicinal Chemistry (HSMC) and the International Liposome Society (ILS) and was sponsored by EFMC and EUFEPS. Professor Gregory Gregoriadis, President of ILS was the Chair of the Congress.
The aim of the Congress was to bring together scientists from different disciplines involved in the research for novel medicines, considering that drug discovery through molecular design and advanced drug delivery are the vanguard of modern therapeutics.
The Congress was a very successful event. It was attended by 175 participants from 18 countries around the world.
The scientific program included 3 Plenary Lectures, 11 Main Lectures, 14 Oral Communications and 78 Posters. The Congress started on Thursday 13, in the afternoon, with lectures on Emerging Technologies in Drug Discovery presented by prominent scientists. In the Welcome Reception at the same evening the participants had the opportunity to discuss and exchange ideas, while enjoying delicious food and wine. Friday 14, had a full day program with interesting lectures on Computational Techniques, Polypharmacology, drug safety predictions, therapeutic targets and mechanisms of actions during the two morning sessions. After the poster session, in the afternoon, Advanced Drug Delivery Systems, liposomes technology and pharmaceutical applications of nanoparticles were presented and discussed. A joint session with the International Society of Pharmacovigilance (ISoP) entitled ‘Drug safety monitoring and beyond’ successfully closed the second Symposium day. Saturday 15, was devoted to optimization of drug delivery, regulatory issues and nanocarriers for therapeutics.
The Symposium closed with short presentations of the four best posters selected by an independent Scientific Committee. The winners were:
Erofili Giannakopoulou (University of Athens, Greece) for the poster:
“NOVEL FLUTIMIDE ANALOGUES TARGETING THE INFLUENZA VIRUS PA ENDONUCLEASE”
Aristeidis Papagiannopoulos (National Hellenic Research Foundation, Greece) for the poster: “LYSOZYME COMPLEXATION WITH BLOCK POLYELECTROLYTE MICELLAR NANOPARTICLES PROBED BY SMALL ANGLE NEUTRON SCATTERING”
Georgios Paraskevopoulos (Charles University, Czech Republic) for the poster:
“NITRO-SUBSTITUTED SALICYLANILIDES: MAINTAINING ANTITUBERCULAR ACTIVITY WHILE REDUCING TOXICITY”
Theodosia Vallianatou (Uppsala University, Sweden) for the poster:
“BLOOD-BRAIN BARRIER DRUG TARGETING BY MASS SPECTROMETRY IMAGING INEARLY ADME PROFILING”
It is in the intentions of the organizing Societies to continue the efforts on such joint meetings and we hope that the 1st International Congress: From Drug Discovery to Drug Delivery will initiate a new series of events creating a tradition towards this direction.
Report on the 16th Hellenic Symposium on Medicinal Chemistry (16th HSMC), January 23-25, 2015 - Patras, Greece
The 16th Hellenic Symposium on Medicinal Chemistry (16th HSMC) was held on January 23-25, 2015 in the city of Patras, at the Conference and Cultural Center of the University of Patras, Greece. The Symposium was organised by the Hellenic Society of Medicinal Chemistry (HSMC), and sponsored by the EFMC, while the Laboratory of Medicinal Chemistry, Department of Pharmacy, University of Patras, Greece, was the local host of the event.
The event, organised biannually for more than 25 years in Greece by HSMC, covered recent advances in the field of Medicinal Chemistry and brought together scientists involved in various disciplines related to drug discovery.
The 16th HSMC was attended by 75 participants from academia, research institutes and industry, coming mainly from Greece. The scientific program involved 4 Plenary Lectures, 8 Main Lectures, 5 Oral Communications and 34 Posters.
Professor Dr Hans-Joachim Knölker (Technical University of Dresden, Germany), Professor Dr Athanassios Giannis (University of Leipzig, Germany), Professor George Kokotos (University of Athens, Greece) and Dr Dimitrios Tzalis (Taros Chemicals GmbH & Co. KG, Dortmund, Germany) were the Invited Speakers of the Symposium.
During the course of the event the participants had the opportunity not only to present their recent research achievements and exchange ideas, but also to strengthen relationships and friendships as well as to explore opportunities for future collaborations.
At the closing of the Symposium, three poster-prizes were awarded to the following recipients, upon the evaluation of an independent scientific committee:
Antonia G. Sarantou (University of Ioannina, Greece) for the poster entitled:
“THE DESIGN AND SYNTHESIS OF N-(SUBSTITUTED) N'-[2-(1H-PYRROL-2-YL-CARBONYL)PHE-NYL]UREAS AS NEW INHIBITORS OF RECEPTOR P2Y12”
Alexandros Stouraitis (National Center for Scientific Research “Demokritos”, Athens, Greece and University of Athens, Greece) for the poster entitled:
“MIXED PHARMACOPHORE fac-[M(OO)(isc)(CO)3] (M = Re, 99mTc) COMPLEXES BEARING 2-(4„-AMINOPHENYL) BENZOTHIAZOLE AND CURCUMIN FOR TUMOR DIAGNOSIS AND THERAPY”
Dionysios Vourtsis (University of Patras, Greece) for the poster entitled:
“expression of the N-terminal domain of anthrax lethal factor AND PREDICTION of its secondary structure via nmr analysis”
The Symposium Co-ordinator, Associate Professor Sotiris Nikolaropoulos, and the Organizing Committee of the 16th HSMC express their sincere thanks to all speakers, poster presenters and the participants who attended the Symposium works and contributed substantially to its success.
The Hellenic Society of Medicinal Chemistry will organise the IXth Joint Meeting in Medicinal Chemistry (IXth JMMC), 7-10 June 2015, in Athens, Greece.
The IXth JMMC follows the tradition created by several European national medicinal chemistry societies to organise these joint scientific events in the years between the biennial International Symposia on Medicinal Chemistry. The principal aim of the JMMCs is to disseminate medicinal chemistry activities and to promote interactions and collaborations between scientists.
Austria, Croatia, Greece, Hungary, Italy, Poland, Slovakia, Slovenia and Czech Republic are the participating countries in the 2015 JMMC edition. The IXth JMMC is an EFMC sponsored event. It will include plenary and keynote lectures, oral communications and poster presentations on a broad range of topics covering Computational Medicinal Chemistry, Advances in Synthetic Approaches and New Technologies in Medicinal Chemistry, Multitarget Drug Design, Natural products as lead compounds, New trends in Chemotherapy, Metabolic diseases, Inflammation, Nuclear receptors as drug targets.
Deadline for abstract submission is March 31, 2015. More information on the IXth JMMC is available at www.jmmc2015.gr.
THE DANISH SOCIETY OF PHARMACOLOGY, TOXICOLOGY, AND MEDICINAL CHEMISTRY (DSFTM) ORGANISES THE SYMPOSIUM 'Virus and Vaccines – Current Challenges' MARCH 26TH, 2015
(…) Furthermore, this year, DSFTM will for the first time organize a medicinal chemistry session at the Danish Chemical Society annual meeting at the University of Southern Denmark in Odense on Thursday, July 11. Confirmed speakers at the session are Prof. Troels Skrydstrup, University of Aarhus, Prof. Kristian Strømgaard, University of Copenhagen and Divisional Director Klaus Bæk Simonsen, Lundbeck. More info will follow later.
For more news and updates from DSFTM, please see www.dsftm.dk
EFMC AND THE LIFE SCIENCES DIVISION OF EuCheMS JOINTLY ORGANISE THE '6th European Conference on Chemistry in the Life Sciences'
The Conference will be held in Lisbon, Portugal, 10th-12th July, 2015. Full program and details can be found at:
Reduced rates are available for students and post-docs.
THE '22nd Young Reasearch Fellows Meeting (YRFM) WAS ORGANISED BY THE FRENCH MEDICINAL CHEMISTRY SOCIETY (SCT)
Biocitech, in Romainville (France), hosted the 22nd Young Research Fellows Meeting (YRFM) during 3 days (February 4 to 6, 2015). This annual event was organised by the French Medicinal Chemistry Society (Société de Chimie Thérapeutique, SCT) (...)
(...) 350 PhD students and postdoctoral researchers coming from 30 countries were encouraged to present their work during the conference through oral communications or poster sessions. Among them more than 70 young fellows had the opportunity to present their work in plenary sessions and more than 150 posters were exposed. This meeting was also punctuated by world-renowned scientists’ lectures (Dr. D. Letourneur (University Paris 13, France), Prof. K.H. Altmann (ETH, Zurich, Switzerland), Prof. M. Botta (University of Siena, Italy), Dr. L. Baerfaker (Bayer, Wuppertal, Germany) and Dr. A. NonellCanals (Mind the Byte, Barcelona, Spain). Careers workshops and interviews with members of biotechnology, start-ups and pharmaceutical companies were also organized. Finally, a panel of experts from European academia and industry awarded 22 best oral and poster presentations. As part of the symposium, 4 young researchers were awarded by the French Medicinal Chemistry Society and the French pharmaceutical group Servier: the prize called ‘Prix d'Encouragement’ was given to Prof. R. Frederick (Université Catholique de Louvain, Belgium) and Dr M. Fontvielle (Centre de Recherche des Cordeliers, Paris, France) to honor their research in medicinal chemistry while the prize called ‘Prix de la Vocation’ was given to E. Deau (ICOA, Université d’Orléans, France) and to M. Bouët (IRCOF, Université de Rouen, France) to reward their poster presentations during the 50th International Conference on Medicinal Chemistry (RICT 2014) held in Rouen.
The 23rd Young Research Fellows Meeting will be held next year in Lille (February 15 to 17, 2016), at the school of Pharmacy. For more information, please visit our website www.sct-asso.fr.
NEWS FROM THE DIVISION OF MEDICINAL CHEMISTRY OF THE ITALIAN CHEMICAL SOCIETY (DCF-SCI)
The Division of Medicinal Chemistry of the Italian Chemical Society has a rich program of events for the year 2015 (…)
(…)9th Joint Meeting in Medicinal Chemistry – Athens, Greece
June 7-10, 2015
The 9th JMMC will be organised by the Hellenic Society of Medicinal Chemistry in Athens (Greece) and is an EFMC sponsored event. The principal aim is to disseminate medicinal chemistry activities carried out mainly in the participating national medicinal chemistry societies of nine European countries (Austria, Croatia, Greece, Hungary, Italy, Poland, Slovakia, Slovenia and Czech Republic) and to promote interactions and collaborations between scientists.
Topics: Computational Medicinal Chemistry to guide lead generation and optimization; Advances in Synthetic Approaches and New Technologies in Medicinal Chemistry; Multitarget Drug Design; Natural products as lead compounds; New trends in Chemotherapy; Metabolic diseases; Inflammation; Nuclear receptors as drug targets
Contact person: Prof. Anna Tsantili-Kakoulidou (President of the Hellenic Society of Medicinal Chemistry), e-mail: email@example.com
16th Recent Development in Pharmaceutical Analysis – Perugia, Italy
June 28-July 1, 2015
Organised by the Group of Pharmaceutical Analysis of the Division of Medicinal Chemistry (Italian Chemical Society), the 16th edition of the International RDPA meeting will be held in Perugia (Italy). The conference brings together scientists, from both academia and industry, mainly involved in biopharmaceutical analysis as applied to drug discovery and development.
Topics: Advanced Methodologies and Instrumentation; Hyphenated techniques; Fundamentals (theories, retention models, chemometrics); (Bio)Pharmaceutical analysis; Food analysis, Nutraceuticals, Functional Food, Natural Products; Proteomics, glycomics, metabolomics; Biomarker discovery; Sample preparation, validation, quality by design, and data processing.
Contact person: Prof. Benedetto Natalini (University of Perugia, Italy), e-mail: firstname.lastname@example.org
35th European School of Medicinal Chemistry – Urbino, Italy
June 28-July 3, 2015
The 35th edition of the European School of Medicinal Chemistry (ESMEC), an EFMC Accredited School, will be held as usually in Urbino (Italy), Campus ”Collegi del Colle e Tridente”. The mission of the ESMEC is to provide participants, PhD students and junior researchers, from both academia and industry, with the most recent advances in the field of medicinal and organic chemistry, pharmacology, molecular biology and analytical/ structural chemistry.
Topics: New avenues in pain therapeutics; Novel Methods to investigate GPCRs-ligand interactions; Photochemistry as an innovative synthetic tool; Hot Topics in medicinal chemistry.
Contact persons: Prof. Carlo De Micheli (Director), e-mail: email@example.com; Dr. Lucia Bedini (Secretary), e-mail: firstname.lastname@example.org.
Spanish-Italian Medicinal Chemistry Congress (SIMMC 2015) - Barcelona, Spain
July 12-15, 2015
Jointly organised by the Spanish Society of Medicinal Chemistry (SEQT) and the Italian Division of Medicinal Chemistry (SCI-DCF), the congress will give the opportunity to delegates to strengthen scientific ties and develop common interests and joint collaborative efforts.
Topics: In addition to updates on choice topics and future trends in medicinal chemistry and drug discovery advances in selected therapeutic areas, the program will cover recent progress in lead identification and optimization, drug design and profiling technologies, as well as highlight current challenges at the interface between chemistry and biology.
23rd National Meeting of Medicinal Chemistry & 9th NPCF – Salerno, Italy
September 6-9, 2015
The 23rd NMMC, joint with the 9th Young Medicinal Chemists Symposium “Nuove Prospettive in Chimica Farmaceutica” (NPCF9) will be held in the Campus of the University of Salerno (Fisciano - Salerno, Italy). The meeting aims to provide a panel of scientists to interact and discuss the latest ideas, scientific breakthroughs and techniques, by offering an exciting chance to debate future changes and topical coverage of key disciplines, as well as to explore for cooperation and collaborations.
Topics: Anti-infective Agents; Biophysics and Analytics in Drug Discovery; Cancer; Cardiovascular Diseases; Central Nervous System; Computer Aided Methods in Medicinal Chemistry; Drug Delivery; Drug Design; Epigenetics; Inflammation; Metabolic Diseases; Nutraceuticals and Nutragenomics; Pharmaceutical Analysis; Pharmaceutical Biotechnologies; Synthetic Methods and Strategies in Medicinal Chemistry.
Contact person: Prof. Gianluca Sbardella, e-mail: email@example.com
Summer School in Pharmaceutical Analysis (SSPA2015) – Rimini, Italy
September 16-18, 2015
SSPA2015, which is an EFMC sponsored school, will be held in Rimini (Italy). The school is aimed at providing PhD students and junior scientists from both academia and industry with the knowledge of the most advanced analytical methodologies as applied to drug discovery and development. As the second part of a three-year cycle on chemical drug manufacturing, nutraceuticals/plant drugs and biopharmaceuticals, SSPA2015 will focus on plant-derived active principles.
Topics: Advanced analytical methodologies for medicinal plant characterization.
Contact person: Prof. Giancarlo Aldini (Director), e-mail: firstname.lastname@example.org
Find out more on www.efmc.info
Newsletter compiled by Gabriele Costantino
Find us on social media